Metformin, a therapy generally used in adults with type 2 diabetes, was linked to short-term improvements in the cardiometabolic health of teenagers with polycystic ovary syndrome (PCOS), a small evidence review found.
Metformin Linked to Improved Metabolic Profile in Teens With PCOS
